APO Research
Talk to an analyst

APO RESEARCH · REPORT

Aesthetic Medicine and Cosmetic Surgery

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Aesthetic Medicine and Cosmetic Surgery Market Outlook and Growth Opportunities 2026

21 December 2025201 pages

Choose your research edition.

Industry ResearchAesthetic Medicine and Cosmetic Surgery Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Aesthetic Medicine and Cosmetic Surgery Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Aesthetic Medicine and Cosmetic Surgery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Aesthetic Medicine and Cosmetic Surgery Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Aesthetic Medicine and Cosmetic Surgery Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Aesthetic Medicine and Cosmetic Surgery market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Aesthetic Medicine and Cosmetic Surgery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Aesthetic Medicine and Cosmetic Surgery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Aesthetic Medicine and Cosmetic Surgery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Aesthetic Medicine and Cosmetic Surgery market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Aesthetic Medicine and Cosmetic Surgery market include The Plastic Surgery Clinic, Syneron Medical, SunevaMedical,, Sientra, Salmon Creek Plastic Surgery, Polytech Health & Aesthetics, Merz Pharma & Co. KGaA, Mentor Worldwide(Johnson & Johnson Services) and HansBiomed Co., Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Aesthetic Medicine and Cosmetic Surgery market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Aesthetic Medicine and Cosmetic Surgery and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Aesthetic Medicine and Cosmetic Surgery revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Aesthetic Medicine and Cosmetic Surgery market.

Aesthetic Medicine and Cosmetic Surgery Segment by Company

The Plastic Surgery Clinic

Syneron Medical

SunevaMedical,

Sientra

Salmon Creek Plastic Surgery

Polytech Health & Aesthetics

Merz Pharma & Co. KGaA

Mentor Worldwide(Johnson & Johnson Services)

HansBiomed Co., Ltd

GC Aesthetics

Galderma S.A. (A Nestle Company

Cynosure (Hologic)

Cutera

Cosmetic Surgery (UK) Limited

BluePlastic Surgery

Bausch Health

Australia Cosmetic Clinics

Anika Therapeutics)

Alma Lasers (Shanghai Fosun Pharmaceuticals)

Allergan, Plc

Aesthetic Medicine and Cosmetic Surgery Segment by Type

Invasive Procedures

Non-surgical Procedure

Aesthetic Medicine and Cosmetic Surgery Segment by Application

Hospitals

Dermatology clinics

Others

Aesthetic Medicine and Cosmetic Surgery Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Aesthetic Medicine and Cosmetic Surgery status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Aesthetic Medicine and Cosmetic Surgery key companies, revenue, market share, and recent developments.

3. To split the Aesthetic Medicine and Cosmetic Surgery breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Aesthetic Medicine and Cosmetic Surgery market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Aesthetic Medicine and Cosmetic Surgery significant trends, drivers, influence factors in global and regions.

6. To analyze Aesthetic Medicine and Cosmetic Surgery competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aesthetic Medicine and Cosmetic Surgery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aesthetic Medicine and Cosmetic Surgery and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aesthetic Medicine and Cosmetic Surgery.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Aesthetic Medicine and Cosmetic Surgery industry.

Chapter 3: Detailed analysis of Aesthetic Medicine and Cosmetic Surgery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Aesthetic Medicine and Cosmetic Surgery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Aesthetic Medicine and Cosmetic Surgery in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Aesthetic Medicine and Cosmetic Surgery Industry Trends Table 2. Aesthetic Medicine and Cosmetic Surgery Industry Drivers Table 3. Aesthetic Medicine and Cosmetic Surgery Industry Opportunities and Challenges Table 4. Aesthetic Medicine and Cosmetic Surgery Industry Restraints Table 5. Global Aesthetic Medicine and Cosmetic Surgery Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Aesthetic Medicine and Cosmetic Surgery Revenue Share by Company (2021-2026) Table 7. Global Aesthetic Medicine and Cosmetic Surgery Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Aesthetic Medicine and Cosmetic Surgery Key Company Manufacturing Base & Headquarters Table 9. Global Aesthetic Medicine and Cosmetic Surgery Company, Product Type & Application Table 10. Global Aesthetic Medicine and Cosmetic Surgery Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Aesthetic Medicine and Cosmetic Surgery by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Invasive Procedures Table 15. Significant Companies of Non-surgical Procedure Table 16. Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type (2021-2026) Table 20. Global Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospitals Table 22. Significant Companies of Dermatology clinics Table 23. Significant Companies of Others Table 24. Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application (2021-2026) Table 28. Global Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application (2027-2032) Table 29. Global Aesthetic Medicine and Cosmetic Surgery Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Region (2021-2026) Table 32. Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Region (2027-2032) Table 34. Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Aesthetic Medicine and Cosmetic Surgery Sales Value Market Share by Country (2021-2026) Table 37. Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Aesthetic Medicine and Cosmetic Surgery Sales Value Market Share by Country (2027-2032) Table 39. The Plastic Surgery Clinic Company Information Table 40. The Plastic Surgery Clinic Business Overview Table 41. The Plastic Surgery Clinic Aesthetic Medicine and Cosmetic Surgery Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. The Plastic Surgery Clinic Aesthetic Medicine and Cosmetic Surgery Product Portfolio Table 43. The Plastic Surgery Clinic Recent Development Table 44. Syneron Medical Company Information Table 45. Syneron Medical Business Overview Table 46. Syneron Medical Aesthetic Medicine and Cosmetic Surgery Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Syneron Medical Aesthetic Medicine and Cosmetic Surgery Product Portfolio Table 48. Syneron Medical Recent Development Table 49. SunevaMedical, Company Information Table 50. SunevaMedical, Business Overview Table 51. SunevaMedical, Aesthetic Medicine and Cosmetic Surgery Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. SunevaMedical, Aesthetic Medicine and Cosmetic Surgery Product Portfolio Table 53. SunevaMedical, Recent Development Table 54. Sientra Company Information Table 55. Sientra Business Overview Table 56. Sientra Aesthetic Medicine and Cosmetic Surgery Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Sientra Aesthetic Medicine and Cosmetic Surgery Product Portfolio Table 58. Sientra Recent Development Table 59. Salmon Creek Plastic Surgery Company Information Table 60. Salmon Creek Plastic Surgery Business Overview Table 61. Salmon Creek Plastic Surgery Aesthetic Medicine and Cosmetic Surgery Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Salmon Creek Plastic Surgery Aesthetic Medicine and Cosmetic Surgery Product Portfolio Table 63. Salmon Creek Plastic Surgery Recent Development Table 64. Polytech Health & Aesthetics Company Information Table 65. Polytech Health & Aesthetics Business Overview Table 66. Polytech Health & Aesthetics Aesthetic Medicine and Cosmetic Surgery Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Polytech Health & Aesthetics Aesthetic Medicine and Cosmetic Surgery Product Portfolio Table 68. Polytech Health & Aesthetics Recent Development Table 69. Merz Pharma & Co. KGaA Company Information Table 70. Merz Pharma & Co. KGaA Business Overview Table 71. Merz Pharma & Co. KGaA Aesthetic Medicine and Cosmetic Surgery Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Merz Pharma & Co. KGaA Aesthetic Medicine and Cosmetic Surgery Product Portfolio Table 73. Merz Pharma & Co. KGaA Recent Development Table 74. Mentor Worldwide(Johnson & Johnson Services) Company Information Table 75. Mentor Worldwide(Johnson & Johnson Services) Business Overview Table 76. Mentor Worldwide(Johnson & Johnson Services) Aesthetic Medicine and Cosmetic Surgery Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Mentor Worldwide(Johnson & Johnson Services) Aesthetic Medicine and Cosmetic Surgery Product Portfolio Table 78. Mentor Worldwide(Johnson & Johnson Services) Recent Development Table 79. HansBiomed Co., Ltd Company Information Table 80. HansBiomed Co., Ltd Business Overview Table 81. HansBiomed Co., Ltd Aesthetic Medicine and Cosmetic Surgery Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. HansBiomed Co., Ltd Aesthetic Medicine and Cosmetic Surgery Product Portfolio Table 83. HansBiomed Co., Ltd Recent Development Table 84. GC Aesthetics Company Information Table 85. GC Aesthetics Business Overview Table 86. GC Aesthetics Aesthetic Medicine and Cosmetic Surgery Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. GC Aesthetics Aesthetic Medicine and Cosmetic Surgery Product Portfolio Table 88. GC Aesthetics Recent Development Table 89. Galderma S.A. (A Nestle Company Company Information Table 90. Galderma S.A. (A Nestle Company Business Overview Table 91. Galderma S.A. (A Nestle Company Aesthetic Medicine and Cosmetic Surgery Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Galderma S.A. (A Nestle Company Aesthetic Medicine and Cosmetic Surgery Product Portfolio Table 93. Galderma S.A. (A Nestle Company Recent Development Table 94. Cynosure (Hologic) Company Information Table 95. Cynosure (Hologic) Business Overview Table 96. Cynosure (Hologic) Aesthetic Medicine and Cosmetic Surgery Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Cynosure (Hologic) Aesthetic Medicine and Cosmetic Surgery Product Portfolio Table 98. Cynosure (Hologic) Recent Development Table 99. Cutera Company Information Table 100. Cutera Business Overview Table 101. Cutera Aesthetic Medicine and Cosmetic Surgery Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Cutera Aesthetic Medicine and Cosmetic Surgery Product Portfolio Table 103. Cutera Recent Development Table 104. Cosmetic Surgery (UK) Limited Company Information Table 105. Cosmetic Surgery (UK) Limited Business Overview Table 106. Cosmetic Surgery (UK) Limited Aesthetic Medicine and Cosmetic Surgery Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Cosmetic Surgery (UK) Limited Aesthetic Medicine and Cosmetic Surgery Product Portfolio Table 108. Cosmetic Surgery (UK) Limited Recent Development Table 109. BluePlastic Surgery Company Information Table 110. BluePlastic Surgery Business Overview Table 111. BluePlastic Surgery Aesthetic Medicine and Cosmetic Surgery Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. BluePlastic Surgery Aesthetic Medicine and Cosmetic Surgery Product Portfolio Table 113. BluePlastic Surgery Recent Development Table 114. Bausch Health Company Information Table 115. Bausch Health Business Overview Table 116. Bausch Health Aesthetic Medicine and Cosmetic Surgery Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Bausch Health Aesthetic Medicine and Cosmetic Surgery Product Portfolio Table 118. Bausch Health Recent Development Table 119. Australia Cosmetic Clinics Company Information Table 120. Australia Cosmetic Clinics Business Overview Table 121. Australia Cosmetic Clinics Aesthetic Medicine and Cosmetic Surgery Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Australia Cosmetic Clinics Aesthetic Medicine and Cosmetic Surgery Product Portfolio Table 123. Australia Cosmetic Clinics Recent Development Table 124. Anika Therapeutics) Company Information Table 125. Anika Therapeutics) Business Overview Table 126. Anika Therapeutics) Aesthetic Medicine and Cosmetic Surgery Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Anika Therapeutics) Aesthetic Medicine and Cosmetic Surgery Product Portfolio Table 128. Anika Therapeutics) Recent Development Table 129. Alma Lasers (Shanghai Fosun Pharmaceuticals) Company Information Table 130. Alma Lasers (Shanghai Fosun Pharmaceuticals) Business Overview Table 131. Alma Lasers (Shanghai Fosun Pharmaceuticals) Aesthetic Medicine and Cosmetic Surgery Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Alma Lasers (Shanghai Fosun Pharmaceuticals) Aesthetic Medicine and Cosmetic Surgery Product Portfolio Table 133. Alma Lasers (Shanghai Fosun Pharmaceuticals) Recent Development Table 134. Allergan, Plc Company Information Table 135. Allergan, Plc Business Overview Table 136. Allergan, Plc Aesthetic Medicine and Cosmetic Surgery Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 137. Allergan, Plc Aesthetic Medicine and Cosmetic Surgery Product Portfolio Table 138. Allergan, Plc Recent Development Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Aesthetic Medicine and Cosmetic Surgery Product Image Figure 2. Global Aesthetic Medicine and Cosmetic Surgery Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Aesthetic Medicine and Cosmetic Surgery Market Size (2021-2032) & (US$ Million) Figure 4. Global Aesthetic Medicine and Cosmetic Surgery Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Invasive Procedures Image Figure 8. Non-surgical Procedure Image Figure 9. Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Aesthetic Medicine and Cosmetic Surgery Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type (2021-2032) Figure 12. Hospitals Image Figure 13. Dermatology clinics Image Figure 14. Others Image Figure 15. Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Aesthetic Medicine and Cosmetic Surgery Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application (2021-2032) Figure 18. Global Aesthetic Medicine and Cosmetic Surgery Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Aesthetic Medicine and Cosmetic Surgery Sales Value (2021-2032) & (US$ Million) Figure 21. North America Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Aesthetic Medicine and Cosmetic Surgery Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Aesthetic Medicine and Cosmetic Surgery Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Aesthetic Medicine and Cosmetic Surgery Sales Value (2021-2032) & (US$ Million) Figure 27. South America Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Aesthetic Medicine and Cosmetic Surgery Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Invasive Procedures
  • Non-surgical Procedure
Applications
  • Hospitals
  • Dermatology clinics
  • Others
Companies covered
  • The Plastic Surgery Clinic
  • Syneron Medical
  • SunevaMedical,
  • Sientra
  • Salmon Creek Plastic Surgery
  • Polytech Health & Aesthetics
  • Merz Pharma & Co. KGaA
  • Mentor Worldwide(Johnson & Johnson Services)
  • HansBiomed Co., Ltd
  • GC Aesthetics
  • Galderma S.A. (A Nestle Company
  • Cynosure (Hologic)
  • Cutera
  • Cosmetic Surgery (UK) Limited
  • BluePlastic Surgery
  • Bausch Health
  • Australia Cosmetic Clinics
  • Anika Therapeutics)
  • Alma Lasers (Shanghai Fosun Pharmaceuticals)
  • Allergan, Plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Aesthetic Medicine and Cosmetic Surgery Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Aesthetic Medicine and Cosmetic Surgery Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Aesthetic Medicine and Cosmetic Surgery Market Dynamics
  1. 2.1 Aesthetic Medicine and Cosmetic Surgery Industry Trends
  2. 2.2 Aesthetic Medicine and Cosmetic Surgery Industry Drivers
  3. 2.3 Aesthetic Medicine and Cosmetic Surgery Industry Opportunities and Challenges
  4. 2.4 Aesthetic Medicine and Cosmetic Surgery Industry Restraints
3 Aesthetic Medicine and Cosmetic Surgery Market by Company
  1. 3.1 Global Aesthetic Medicine and Cosmetic Surgery Company Revenue Ranking in 2025
  2. 3.2 Global Aesthetic Medicine and Cosmetic Surgery Revenue by Company (2021-2026)
  3. 3.3 Global Aesthetic Medicine and Cosmetic Surgery Company Ranking (2024-2026)
  4. 3.4 Global Aesthetic Medicine and Cosmetic Surgery Company Manufacturing Base and Headquarters
  5. 3.5 Global Aesthetic Medicine and Cosmetic Surgery Company Product Type and Application
  6. 3.6 Global Aesthetic Medicine and Cosmetic Surgery Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Aesthetic Medicine and Cosmetic Surgery Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Aesthetic Medicine and Cosmetic Surgery Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Aesthetic Medicine and Cosmetic Surgery Market by Type
  1. 4.1 Aesthetic Medicine and Cosmetic Surgery Type Introduction
  2. 4.1.1 Invasive Procedures
  3. 4.1.2 Non-surgical Procedure
  4. 4.2 Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Type
  5. 4.2.1 Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Type (2021-2032)
  7. 4.2.3 Global Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type (2021-2032)
5 Aesthetic Medicine and Cosmetic Surgery Market by Application
  1. 5.1 Aesthetic Medicine and Cosmetic Surgery Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Dermatology clinics
  4. 5.1.3 Others
  5. 5.2 Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Application
  6. 5.2.1 Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Application (2021-2032)
  8. 5.2.3 Global Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application (2021-2032)
6 Aesthetic Medicine and Cosmetic Surgery Regional Value Analysis
  1. 6.1 Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Region (2021-2032)
  3. 6.2.1 Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Region: 2021-2026
  4. 6.2.2 Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Aesthetic Medicine and Cosmetic Surgery Sales Value (2021-2032)
  7. 6.3.2 North America Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Aesthetic Medicine and Cosmetic Surgery Sales Value (2021-2032)
  10. 6.4.2 Europe Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Aesthetic Medicine and Cosmetic Surgery Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Aesthetic Medicine and Cosmetic Surgery Sales Value (2021-2032)
  16. 6.6.2 South America Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Aesthetic Medicine and Cosmetic Surgery Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Country, 2025 VS 2032
7 Aesthetic Medicine and Cosmetic Surgery Country-level Value Analysis
  1. 7.1 Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Country (2021-2032)
  3. 7.2.1 Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Country (2021-2026)
  4. 7.2.2 Global Aesthetic Medicine and Cosmetic Surgery Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Aesthetic Medicine and Cosmetic Surgery Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Aesthetic Medicine and Cosmetic Surgery Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 The Plastic Surgery Clinic
  2. 8.1.1 The Plastic Surgery Clinic Company Information
  3. 8.1.2 The Plastic Surgery Clinic Business Overview
  4. 8.1.3 The Plastic Surgery Clinic Aesthetic Medicine and Cosmetic Surgery Revenue and Gross Margin (2021-2026)
  5. 8.1.4 The Plastic Surgery Clinic Aesthetic Medicine and Cosmetic Surgery Product Portfolio
  6. 8.1.5 The Plastic Surgery Clinic Recent Developments
  7. 8.2 Syneron Medical
  8. 8.2.1 Syneron Medical Company Information
  9. 8.2.2 Syneron Medical Business Overview
  10. 8.2.3 Syneron Medical Aesthetic Medicine and Cosmetic Surgery Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Syneron Medical Aesthetic Medicine and Cosmetic Surgery Product Portfolio
  12. 8.2.5 Syneron Medical Recent Developments
  13. 8.3 SunevaMedical,
  14. 8.3.1 SunevaMedical, Company Information
  15. 8.3.2 SunevaMedical, Business Overview
  16. 8.3.3 SunevaMedical, Aesthetic Medicine and Cosmetic Surgery Revenue and Gross Margin (2021-2026)
  17. 8.3.4 SunevaMedical, Aesthetic Medicine and Cosmetic Surgery Product Portfolio
  18. 8.3.5 SunevaMedical, Recent Developments
  19. 8.4 Sientra
  20. 8.4.1 Sientra Company Information
  21. 8.4.2 Sientra Business Overview
  22. 8.4.3 Sientra Aesthetic Medicine and Cosmetic Surgery Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sientra Aesthetic Medicine and Cosmetic Surgery Product Portfolio
  24. 8.4.5 Sientra Recent Developments
  25. 8.5 Salmon Creek Plastic Surgery
  26. 8.5.1 Salmon Creek Plastic Surgery Company Information
  27. 8.5.2 Salmon Creek Plastic Surgery Business Overview
  28. 8.5.3 Salmon Creek Plastic Surgery Aesthetic Medicine and Cosmetic Surgery Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Salmon Creek Plastic Surgery Aesthetic Medicine and Cosmetic Surgery Product Portfolio
  30. 8.5.5 Salmon Creek Plastic Surgery Recent Developments
  31. 8.6 Polytech Health & Aesthetics
  32. 8.6.1 Polytech Health & Aesthetics Company Information
  33. 8.6.2 Polytech Health & Aesthetics Business Overview
  34. 8.6.3 Polytech Health & Aesthetics Aesthetic Medicine and Cosmetic Surgery Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Polytech Health & Aesthetics Aesthetic Medicine and Cosmetic Surgery Product Portfolio
  36. 8.6.5 Polytech Health & Aesthetics Recent Developments
  37. 8.7 Merz Pharma & Co. KGaA
  38. 8.7.1 Merz Pharma & Co. KGaA Company Information
  39. 8.7.2 Merz Pharma & Co. KGaA Business Overview
  40. 8.7.3 Merz Pharma & Co. KGaA Aesthetic Medicine and Cosmetic Surgery Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Merz Pharma & Co. KGaA Aesthetic Medicine and Cosmetic Surgery Product Portfolio
  42. 8.7.5 Merz Pharma & Co. KGaA Recent Developments
  43. 8.8 Mentor Worldwide(Johnson & Johnson Services)
  44. 8.8.1 Mentor Worldwide(Johnson & Johnson Services) Company Information
  45. 8.8.2 Mentor Worldwide(Johnson & Johnson Services) Business Overview
  46. 8.8.3 Mentor Worldwide(Johnson & Johnson Services) Aesthetic Medicine and Cosmetic Surgery Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Mentor Worldwide(Johnson & Johnson Services) Aesthetic Medicine and Cosmetic Surgery Product Portfolio
  48. 8.8.5 Mentor Worldwide(Johnson & Johnson Services) Recent Developments
  49. 8.9 HansBiomed Co., Ltd
  50. 8.9.1 HansBiomed Co., Ltd Company Information
  51. 8.9.2 HansBiomed Co., Ltd Business Overview
  52. 8.9.3 HansBiomed Co., Ltd Aesthetic Medicine and Cosmetic Surgery Revenue and Gross Margin (2021-2026)
  53. 8.9.4 HansBiomed Co., Ltd Aesthetic Medicine and Cosmetic Surgery Product Portfolio
  54. 8.9.5 HansBiomed Co., Ltd Recent Developments
  55. 8.10 GC Aesthetics
  56. 8.10.1 GC Aesthetics Company Information
  57. 8.10.2 GC Aesthetics Business Overview
  58. 8.10.3 GC Aesthetics Aesthetic Medicine and Cosmetic Surgery Revenue and Gross Margin (2021-2026)
  59. 8.10.4 GC Aesthetics Aesthetic Medicine and Cosmetic Surgery Product Portfolio
  60. 8.10.5 GC Aesthetics Recent Developments
  61. 8.11 Galderma S.A. (A Nestle Company
  62. 8.11.1 Galderma S.A. (A Nestle Company Company Information
  63. 8.11.2 Galderma S.A. (A Nestle Company Business Overview
  64. 8.11.3 Galderma S.A. (A Nestle Company Aesthetic Medicine and Cosmetic Surgery Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Galderma S.A. (A Nestle Company Aesthetic Medicine and Cosmetic Surgery Product Portfolio
  66. 8.11.5 Galderma S.A. (A Nestle Company Recent Developments
  67. 8.12 Cynosure (Hologic)
  68. 8.12.1 Cynosure (Hologic) Company Information
  69. 8.12.2 Cynosure (Hologic) Business Overview
  70. 8.12.3 Cynosure (Hologic) Aesthetic Medicine and Cosmetic Surgery Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Cynosure (Hologic) Aesthetic Medicine and Cosmetic Surgery Product Portfolio
  72. 8.12.5 Cynosure (Hologic) Recent Developments
  73. 8.13 Cutera
  74. 8.13.1 Cutera Company Information
  75. 8.13.2 Cutera Business Overview
  76. 8.13.3 Cutera Aesthetic Medicine and Cosmetic Surgery Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cutera Aesthetic Medicine and Cosmetic Surgery Product Portfolio
  78. 8.13.5 Cutera Recent Developments
  79. 8.14 Cosmetic Surgery (UK) Limited
  80. 8.14.1 Cosmetic Surgery (UK) Limited Company Information
  81. 8.14.2 Cosmetic Surgery (UK) Limited Business Overview
  82. 8.14.3 Cosmetic Surgery (UK) Limited Aesthetic Medicine and Cosmetic Surgery Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Cosmetic Surgery (UK) Limited Aesthetic Medicine and Cosmetic Surgery Product Portfolio
  84. 8.14.5 Cosmetic Surgery (UK) Limited Recent Developments
  85. 8.15 BluePlastic Surgery
  86. 8.15.1 BluePlastic Surgery Company Information
  87. 8.15.2 BluePlastic Surgery Business Overview
  88. 8.15.3 BluePlastic Surgery Aesthetic Medicine and Cosmetic Surgery Revenue and Gross Margin (2021-2026)
  89. 8.15.4 BluePlastic Surgery Aesthetic Medicine and Cosmetic Surgery Product Portfolio
  90. 8.15.5 BluePlastic Surgery Recent Developments
  91. 8.16 Bausch Health
  92. 8.16.1 Bausch Health Company Information
  93. 8.16.2 Bausch Health Business Overview
  94. 8.16.3 Bausch Health Aesthetic Medicine and Cosmetic Surgery Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Bausch Health Aesthetic Medicine and Cosmetic Surgery Product Portfolio
  96. 8.16.5 Bausch Health Recent Developments
  97. 8.17 Australia Cosmetic Clinics
  98. 8.17.1 Australia Cosmetic Clinics Company Information
  99. 8.17.2 Australia Cosmetic Clinics Business Overview
  100. 8.17.3 Australia Cosmetic Clinics Aesthetic Medicine and Cosmetic Surgery Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Australia Cosmetic Clinics Aesthetic Medicine and Cosmetic Surgery Product Portfolio
  102. 8.17.5 Australia Cosmetic Clinics Recent Developments
  103. 8.18 Anika Therapeutics)
  104. 8.18.1 Anika Therapeutics) Company Information
  105. 8.18.2 Anika Therapeutics) Business Overview
  106. 8.18.3 Anika Therapeutics) Aesthetic Medicine and Cosmetic Surgery Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Anika Therapeutics) Aesthetic Medicine and Cosmetic Surgery Product Portfolio
  108. 8.18.5 Anika Therapeutics) Recent Developments
  109. 8.19 Alma Lasers (Shanghai Fosun Pharmaceuticals)
  110. 8.19.1 Alma Lasers (Shanghai Fosun Pharmaceuticals) Company Information
  111. 8.19.2 Alma Lasers (Shanghai Fosun Pharmaceuticals) Business Overview
  112. 8.19.3 Alma Lasers (Shanghai Fosun Pharmaceuticals) Aesthetic Medicine and Cosmetic Surgery Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Alma Lasers (Shanghai Fosun Pharmaceuticals) Aesthetic Medicine and Cosmetic Surgery Product Portfolio
  114. 8.19.5 Alma Lasers (Shanghai Fosun Pharmaceuticals) Recent Developments
  115. 8.20 Allergan, Plc
  116. 8.20.1 Allergan, Plc Company Information
  117. 8.20.2 Allergan, Plc Business Overview
  118. 8.20.3 Allergan, Plc Aesthetic Medicine and Cosmetic Surgery Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Allergan, Plc Aesthetic Medicine and Cosmetic Surgery Product Portfolio
  120. 8.20.5 Allergan, Plc Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst